The use of COA in patient-centered drug development: part 2
COA in PROgress
Evolution of Patient-Reported Outcomes in Health Technology Assessment
Exploring the shift towards scientifically evaluating medicine efficacy using patient-reported outcomes (PROs) and the significance of capturing holistic patient experiences in healthcare systems, particularly in complex diseases. Emphasizing the value of well-developed PRO instruments in drug development and the promising prospects of incorporating patient experience data into HTA processes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
